HARVARD BIOSCIENCE INC — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-05-31

Reporting Person: UVEGES GEORGE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-31	Common Stock	A	5906	—	Acquired	24309	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-31	Stock option (right to buy)	$5.08	A	11400	Acquired	2023-05-31	Common Stock, par value $0.01 per share (11400)	Direct

Footnotes

F1: Includes a deferred stock award of 5,906 restricted stock units which shall fully vest on May 31, 2014.

F2: Includes (a) deferred stock award of 5,906 restricted stock units which shall fully vest on May 31, 2014; (b) a deferred stock award of 8,403 restricted stock units which vest in equal installments on June 1, 2013, June 1, 2014, and June 1, 2015; and (c) 10,000 shares of common stock held by Mr. Uveges.

F3: The options shall fully vest on May 31, 2014.